Detection of serum antibodies to M. leprae major membrane protein-II in leprosy patients from Indonesia.

BACKGROUND Sero-diagnostic methods are the easiest way of diagnosing an infectious disease in developing countries. In leprosy, phenolic glycolipid-1 (PGL-I) based methods for the detection of leprosy are currently available, but the use of these methods has been hindered due to the inherent problems of sensitivity. We previously showed that antibodies to Major Membrane Protein-II (MMP-II) derived from Mycobacterium leprae could be used to diagnose leprosy in Japan. METHODS Sera from patients and healthy individuals were collected with informed consent and the anti-MMP-II antibody levels of the sera were measured by enzyme-linked immunosorbent assay. The study was conducted at South Sulawesi and Bali, in Indonesia. The study population included 40 each of multibacillary leprosy and paucibacillary leprosy patients, 30 tuberculosis and 16 patients with typhoid. RESULTS We evaluated the anti-MMP-II antibody levels in Indonesian individuals. The cut-off value was determined from receiver operator characteristic curve as 0.124 using the O.D. titers for patients with multibacillary leprosy, so that the sensitivity of the test was 97.5% and the specificity taking healthy individuals as controls was 984%. Using the determined cut-off values, 98% of multibacillary (MB) leprosy and 48% of paucibacillary (PB) leprosy patients had positive levels of anti-MMP-II antibodies, 13% of patients with typhoid and 22% of the household contacts of MB leprosy had positive levels of anti-MMP-II antibodies. CONCLUSIONS Our results suggest that measuring anti-MMP-II antibody levels could facilitate the detection of leprosy in endemic countries.

[1]  T. Fujiwara,et al.  Serological Diagnosis of Leprosy in Patients in Vietnam by Enzyme-Linked Immunosorbent Assay with Mycobacterium leprae-Derived Major Membrane Protein II , 2008, Clinical and Vaccine Immunology.

[2]  G. Ireton,et al.  Use of Protein Antigens for Early Serological Diagnosis of Leprosy , 2007, Clinical and Vaccine Immunology.

[3]  Kazuo Kobayashi,et al.  Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. , 2007, FEMS microbiology letters.

[4]  Ajay Kumar,et al.  Detection of antibodies against Mycobacterium leprae culture filtrate protein-10 in leprosy patients. , 2006, Journal of medical microbiology.

[5]  T. Ottenhoff,et al.  Evaluation of Recombinant Serine‐rich 45‐kDa Antigen (ML0411) for Detection of Antibodies in Leprosy Patients , 2006, Scandinavian journal of immunology.

[6]  J. Spencer,et al.  Identification of an Immunomodulating Agent from Mycobacterium leprae , 2005, Infection and Immunity.

[7]  P. Klatser,et al.  Simple and Fast Lateral Flow Test for Classification of Leprosy Patients and Identification of Contacts with High Risk of Developing Leprosy , 2003, Journal of Clinical Microbiology.

[8]  P. Klatser,et al.  The use of whole blood in a dipstick assay for detection of antibodies to Mycobacterium leprae: a field evaluation. , 1998, FEMS immunology and medical microbiology.

[9]  P. Klatser,et al.  Evaluation of the Mycobacterium leprae particle agglutination (MLPA) test as a tool in the epidemiology of leprosy in high prevalence village in South Sulawesi, Indonesia. , 1995, Southeast Asian Journal of Tropical Medicine and Public Health.

[10]  R. G. Deshpande,et al.  Immunoaffinity chromatographic isolation of a high molecular weight seroreactive protein from Mycobacterium leprae cell sonicate. , 1995, FEMS immunology and medical microbiology.

[11]  D. Smith,et al.  Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae , 1994, The Journal of experimental medicine.

[12]  P. Brennan,et al.  The major native proteins of the leprosy bacillus. , 1990, The Journal of biological chemistry.

[13]  Y. Nishimura,et al.  Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field , 1990, Journal of clinical microbiology.

[14]  Job Ck,et al.  Nerve damage in leprosy. , 1989 .

[15]  C. K. Job,et al.  Nerve damage in leprosy. , 1989, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[16]  P. Brennan,et al.  Chemical synthesis of the trisaccharide unit of the species-specific phenolic glycolipid from Mycobacterium leprae. , 1987, Carbohydrate research.

[17]  Ridley Ds,et al.  Classification of leprosy according to immunity. A five-group system. , 1966 .

[18]  D. Ridley,et al.  Classification of leprosy according to immunity. A five-group system. , 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.